SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-22-000044
Filing Date
2022-01-05
Accepted
2022-01-05 19:05:36
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 dermata_fm4jan32022.html 4  
1 dermata_fm4jan32022.xml 4 3852
  Complete submission text file 0000905718-22-000044.txt   5231
Mailing Address C/O CONATUS PHARMACEUTICALS INC. 16745 WEST BERNARDO DRIVE, SUITE 200 SAN DIEGO CA 92127
Business Address
Scott Kathleen D. (Reporting) CIK: 0001794284 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40739 | Film No.: 22513032

Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Issuer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations